Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioanalysis

• Publication date

  2017-07-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.4155/bio-2017-0020PMID 28692306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Insulin Reloaded

  2014cited by this paper
• Ultrasensitive enzyme-linked immunosorbent assay (ELISA) of proteins by combination with the thio-NAD cycling method

  2014cited by this paper
• Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.

  2013cited by this paper
• Advances in the quantitation of therapeutic insulin analogues by LC-MS/MS.

  2013cited by this paper
• Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.

  2011cited by this paper
• Oral insulin – a review of current status

  2010cited by this paper
• Homogeneous Insulin and C-Peptide Sensors for Rapid Assessment of Insulin and C-Peptide Secretion by the Islets

  2010cited by this paper
• Inhaled insulin forms toxic pulmonary amyloid aggregates.

  2010cited by this paper
• A dose range finding study of novel oral insulin (IN‐105) under fed conditions in type 2 diabetes mellitus subjects

  2010cited by this paper
• Toward standardization of insulin immunoassays.

  2009cited by this paper
• Oral Insulin and Buccal Insulin: A Critical Reappraisal

  2009cited by this paper
• The Physiological Rationale for Oral Insulin Administration

  2004cited by this paper
• Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

  2003cited by this paper
• Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules

  2003cited by this paper
• VALIDITY AND USE OF A NON-PARALLEL INSULIN ASSAY FOR PHARMACOKINETIC STUDIES OF THE RAPID-ACTING INSULIN ANALOGUE, INSULIN ASPART

  2001cited by this paper
• A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies.

  2000cited by this paper
• Sensitive RIA for the specific determination of insulin lispro.

  1999cited by this paper
• Humalog, a rapidly absorbed analog of human insulin, determined with Coat-A-Count insulin radioimmunoassay.

  1995cited by this paper
• Preparation of ligand-free human serum for radioimmunoassay by adsorption on activated charcoal.

  1978cited by this paper

• Development of an immunoassay lollipop using syringe-autoinjected visual distance readout for point-of-care testing

  2025cites this paper
• Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals

  2022cites this paper
• A sustained zero-order release carrier for long-acting, peakless basal insulin therapy.

  2020cites this paper
• Efficient detection of pre-proinsulin by double antibody sandwich ELISA

  2020cites this paper
• Controlling insulin release from reverse hexagonal (HII) liquid crystalline mesophase by enzymatic lipolysis.

  2018cites this paper